Search

Author/Creator Qualls, David

1. CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: a preclinical model and initial clinical experience. Issue 2 (16th February 2022)

Authors:
Palomba, M Lia; Qualls, David; Monette, Sebastien; Sethi, Shenon; Dogan, Ahmet; Roshal, Mikhail; Senechal, Brigitte; Wang, Xiuyan; Rivière, Isabelle; Sadelain, Michel; Brentjens, Renier J; Park, Jae H; Smith, Eric L
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 2(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Long‐term outcomes of patients with limited‐stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era. (9th December 2022)

Authors:
Qualls, David; Imber, Brandon S.; Okwali, Michelle; Hamlin, Paul A.; Kumar, Anita; Lahoud, Oscar B.; Matasar, Matthew J.; Noy, Ariela; Owens, Colette; Zelenetz, Andrew D.; North, Victoria S.; Schöder, Heiko; Dogan, Ahmet; Salles, Gilles; Yahalom, Joachim; Falchi, Lorenzo
Journal:
British journal of haematology
Issue:
Volume 200:Number 4(2023)
Page Start:
524
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Positron emission tomography as an adjuvant diagnostic test in the evaluation of checkpoint inhibitor-associated acute interstitial nephritis. Issue 1 (21st December 2019)

Authors:
Qualls, David; Seethapathy, Harish; Bates, Halla; Tajmir, Shahein; Heidari, Pedram; Endres, Paul; Reynolds, Kerry; Lawrence, Donald; Sise, Meghan
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗